Who owns Arbutus Biopharma?
- Ticker: ABUS
- CUSIP Number: 03879j100
Tip: Access positions for across all investors
Analyze quarterly positions in Arbutus Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Arbutus Biopharma stock
Who bought or sold Arbutus Biopharma this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Whitefort Capital Management | 13M | $33M | 11% | Dec 2023 |
|
Vanguard Group | 6.0M | $15M | 1% | Dec 2023 |
|
Hudson Bay Capital Management | 4.1M | $10M | 0% | Dec 2023 |
|
ADAR1 Capital Management | 3.6M | $9.1M | 100% | Dec 2023 |
|
Centiva Capital | 2.2M | $5.4M | 103% | Dec 2023 |
|
Citadel Advisors | 2.1M | $5.2M | -3% | Dec 2023 |
|
Millennium Management | 1.5M | $3.8M | -3% | Dec 2023 |
|
Advisor Group Holdings | 1.4M | $3.4M | 0% | Dec 2023 |
|
FourWorld Capital Management | 1.1M | $2.7M | -19% | Dec 2023 |
|
Citigroup | 880k | $2.2M | 67% | Dec 2023 |
|
Assenagon Asset Management | 818k | $2.0M | 0% | Dec 2023 |
|
Bank of New York Mellon | 457k | $1.1M | 1% | Dec 2023 |
|
Caption Management | 443k | $1.1M | 10% | Dec 2023 |
|
Kennedy Capital Management | 387k | $968k | -1% | Dec 2023 |
|
Barclays | 366k | $914k | 178% | Dec 2023 |
|
Bank Of Montreal | 352k | $893k | 10% | Dec 2023 |
|
Charles Schwab Investment Management | 349k | $873k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 292k | $730k | 21% | Dec 2023 |
|
Two Sigma Investments | 204k | $510k | 705% | Dec 2023 |
|
Tejara Capital | 180k | $450k | 0% | Dec 2023 |
|
Rhumbline Advisers | 165k | $412k | -2% | Dec 2023 |
|
UBS Group | 140k | $350k | 124% | Dec 2023 |
|
Clear Harbor Asset Management | 139k | $348k | 6% | Dec 2023 |
|
Goldman Sachs Group | 127k | $317k | -38% | Dec 2023 |
|
Jpmorgan Chase & Co | 116k | $289k | -3% | Dec 2023 |
|
Royal Bank of Canada | 107k | $265k | -8% | Dec 2023 |
|
Point72 Asset Management | 105k | $263k | 100% | Dec 2023 |
|
Simplex Trading | 105k | $261k | 311% | Dec 2023 |
|
Jane Street | 97k | $241k | 100% | Dec 2023 |
|
Alliancebernstein | 96k | $240k | 5% | Dec 2023 |
|
Bank of America Corporation | 92k | $230k | 1% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 67k | $166k | -4% | Dec 2023 |
|
American International | 63k | $157k | 1% | Dec 2023 |
|
LMR Partners | 60k | $150k | 5% | Dec 2023 |
|
MetLife Investment Advisors | 59k | $148k | 0% | Dec 2023 |
|
Cowen And Company | 50k | $125k | 100% | Dec 2023 |
|
Gts Securities | 48k | $121k | 336% | Dec 2023 |
|
SG Americas Securities | 46k | $115k | 15% | Dec 2023 |
|
Principal Financial Group | 46k | $114k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 45k | $113k | -1% | Dec 2023 |
|
Wells Fargo & Company | 38k | $94k | 17% | Dec 2023 |
|
Florida State Board of Administration | 36k | $90k | 0% | Dec 2023 |
|
Verus Capital Partners | 32k | $80k | -3% | Dec 2023 |
|
Two Sigma Advisers | 31k | $78k | 100% | Dec 2023 |
|
T. Rowe Price Associates | 30k | $75k | 11% | Dec 2023 |
|
Scotia Capital | 29k | $73k | 0% | Dec 2023 |
|
Moneta Group Investment Advisors | 25k | $63k | 9% | Dec 2023 |
|
Premier Path Wealth Partners | 22k | $56k | 100% | Dec 2023 |
|
Kades & Cheifetz | 20k | $50k | 0% | Dec 2023 |
|
China Universal Asset Management | 19k | $49k | 352% | Dec 2023 |
|
Virtu Financial | 18k | $45k | 100% | Dec 2023 |
|
Brevan Howard Capital Management | 18k | $44k | 100% | Dec 2023 |
|
Buckingham Asset Management | 18k | $44k | 0% | Dec 2023 |
|
Arete Wealth Advisors | 15k | $38k | 0% | Dec 2023 |
|
Amalgamated Bank | 15k | $37k | -7% | Dec 2023 |
|
Creative Planning | 15k | $36k | 100% | Dec 2023 |
|
WMG Financial Advisors | 13k | $32k | 0% | Dec 2023 |
|
Legal & General Group | 12k | $31k | 0% | Dec 2023 |
|
Front Row Advisors | 11k | $26k | 0% | Dec 2023 |
|
Pathstone Holdings | 10k | $25k | 100% | Dec 2023 |
|
Summit Investment Advisors | 9.1k | $23k | 0% | Dec 2023 |
|
Cubist Systematic Strategies | 7.2k | $18k | 100% | Dec 2023 |
|
Dagco | 6.3k | $16k | 100% | Dec 2023 |
|
Cambridge Trust Company | 5.0k | $13k | 0% | Dec 2023 |
|
Cutler | 4.5k | $11k | 0% | Dec 2023 |
|
Steward Partners Investment Advisory | 4.0k | $10k | 0% | Dec 2023 |
|
NISA Investment Advisors | 3.8k | $9.6k | 2% | Dec 2023 |
|
Financial Synergies Wealth Advisors | 3.6k | $9.3k | -51% | Mar 2024 |
|
Signature | 3.0k | $7.5k | -21% | Dec 2023 |
|
Metropolitan Life Insurance Company | 3.0k | $7.4k | -52% | Dec 2023 |
|
Russell Investments | 2.3k | $5.7k | -45% | Dec 2023 |
|
National Bank Of Canada /fi/ | 1.8k | $4.7k | 0% | Dec 2023 |
|
CWM | 1.7k | $4.0k | 1087% | Mar 2024 |
|
Benjamin F. Edwards & Company | 1.1k | $3.0k | -76% | Dec 2023 |
|
Harbor Investment Advisory | 803.00 | $2.1k | 0% | Mar 2024 |
|
Parallel Advisors | 550.00 | $1.4k | 0% | Dec 2023 |
|
Blue Bell Private Wealth Management | 500.00 | $1.3k | 0% | Dec 2023 |
|
Daiwa Securities Group | 395.00 | $999.982000 | 0% | Dec 2023 |
|
Lindbrook Capital | 284.00 | $710.000000 | 100% | Dec 2023 |
|
Quadrant Capital | 277.00 | $692.998600 | -70% | Dec 2023 |
|
Private Wealth Management Group | 242.00 | $605.000000 | 100% | Dec 2023 |
|
Pnc Financial Services | 208.00 | $520.000000 | 100% | Dec 2023 |
|
GAMMA Investing | 187.00 | $481.992500 | 0% | Mar 2024 |
|
Who sold out of Arbutus Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Kepos Capital | Sep 2023 | 156k | $316k |
AQR Capital Management | Sep 2023 | 41k | $82k |
Virtus ETF Advisers | Sep 2023 | 40k | $81k |
Victory Capital Management | Sep 2023 | 14k | $28k |
Us Bancorp | Sep 2023 | 1.9k | $3.9k |